在SF3B1-突变骨髓质疏松症候群中,克隆性进展的明显路径
Martina Sarchi1, Courtnee A Clough2, Anna Gallì3
1University of Pavia, Pavia, Italy.
Blood advances
|April 6, 2025
概括
带有SF3B1突变的骨髓发育综合征 (MDS) 的结果各不相同. 像RUNX1或STAG2这样的共同突变改变了造血干细胞程序,通过不同的分子途径影响了疾病的进展.
科学领域:
- 血液学 血液学 血液学
- 癌症遗传学 癌症遗传学
- 干细胞生物学 干细胞生物学
背景情况:
- 骨髓发育综合征 (MDS) 是具有多种遗传驱动因素的克隆干细胞疾病.
- 具有SF3B1突变的MDS通常表明预后有利.
- 共同突变对SF3B1-突变型造血干细胞和原始细胞 (HSPCs) 的影响仍然不完全理解.
研究的目的:
- 调查高风险的共同突变如何影响SF3B1突变HSPCs的行为.
- 根据共同突变模式阐明驱动MDS进展的独特分子和细胞机制.
主要方法:
- 具有SF3B1突变的MDS患者的综合临床和分子分析.
- 在原始和诱导多能干细胞 (iPSC) 衍生的人类HSPC中进行基因编辑.
- 对转录程序和SF3B1突变HSPCs与共突变的分化进行分析.
主要成果:
- 高风险的共同突变 (RUNX1,STAG2) 在SF3B1突变的HSPC中差异地影响髓状细胞系程序.
- 与晚期疾病相关的RUNX1和STAG2突变对髓状细胞分化表现出相反的影响.
- 不同的SF3B1突变HSPC亚群被高风险RUNX1和STAG2突变扩展,但不是低风险TET2突变.
结论:
- 从低风险的MDS向高风险的MDS的进展涉及不同的分子和细胞路径,这些路径是由特定的共变特征决定的.
- 了解这些共同突变相互作用对于预测MDS临床过程和开发向疗法至关重要.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Lineage Commitment
2.9K
Commitment is the process whereby stem cells:
2.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


